UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.928-938

2017

Volltextzugriff (PDF)

Asthma is associated with enhanced thrombin formation and impaired fibrinolysis

Clinical and experimental allergy, 2016-07, Vol.46 (7), p.932-944

2016

Volltextzugriff (PDF)

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

Clinical ophthalmology (Auckland, N.Z.), 2023-01, Vol.17, p.735-746

2023

Volltextzugriff (PDF)

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.79-87

2017

Volltextzugriff (PDF)

Increased expression of collagen receptors: α1β1 and α2β1 integrins on blood eosinophils in bronchial asthma

Clinical and experimental allergy, 2006-09, Vol.36 (9), p.1184-1191

2006

Volltextzugriff (PDF)

Dyspnea is Related to Family Functioning in Adult Asthmatics

The Journal of asthma, 2009-01, Vol.46 (3), p.280-283

2009

Volltextzugriff (PDF)

Effets sur la sévérité de la dermatite atopique reflétée par les scores EASI et SCORAD chez les patients traités par némolizumab

Annales de Dermatologie et de Vénéréologie - FMC, 2022-11, Vol.2 (8), p.A320

2022

Volltextzugriff (PDF)

005 Humanized anti-interleukin-31 receptor A antibody nemolizumab (CIM331) suppresses pruritus and improves eczema in patients with moderate-to-severe atopic dermatitis

Journal of investigative dermatology, 2016-09, Vol.136 (9), p.S161-S161

2016

Volltextzugriff (PDF)

C33 NOVEL BIOMARKERS IN LUNG DISEASE: Impaired Fibrinolysis And Lower Levels Of Plasma α2-Macroglobulin Are Associated With An Increased Risk Of Severe Asthma Exacerbations

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

Journal of clinical immunology, 2017-08, Vol.37 (6), p.603-612

2017

Volltextzugriff (PDF)

Étude de phase 2b sur némolizumab chez des patients adultes présentant une dermatite atopique modérée à sévère associée à un prurit sévère

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A109-A109

2019

Volltextzugriff (PDF)

D31 NOVEL MECHANISMS OF ALLERGY AND AIRWAY INFLAMMATION: Enhanced Thrombin Formation And Impaired Fibrinolysis In Persistent Asthma

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Autoimmune vasculitis and aortic stenosis in aspirin‐induced asthma (AIA)

Allergy (Copenhagen), 1997-03, Vol.52 (3), p.352-354

1997

Volltextzugriff (PDF)

Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function

The European respiratory journal, 2012-02, Vol.39 (2), p.279-289

2012

Volltextzugriff (PDF)

Increased expression of collagen receptors: α 1 β 1 and α 2 β 1 integrins on blood eosinophils in bronchial asthma

Clinical and experimental allergy, 2006-09, Vol.36 (9), p.1184-1191

2006

Volltextzugriff (PDF)

Increased expression of collagen receptors: alpha sub(1) beta sub(1) and alpha sub(2) beta sub(1) integrins on blood eosinophils in bronchial asthma

Clinical and experimental allergy, 2006-09, Vol.36 (9), p.1184-1191

2006

Volltextzugriff (PDF)

Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma

Clinical and experimental allergy, 2006-09, Vol.36 (9), p.1184-1191

2006

Volltextzugriff (PDF)

Changeability of respiratory tract and skin symptoms in patients with asthma-prurigo syndrome under the influence of emotional and environmental factors

Przeglad lekarski, 1998, Vol.55 (5), p.242

1998

Volltextzugriff (PDF)

Some clinical symptoms and allergens on asthma-prurigo syndrome

Przeglad lekarski, 1998, Vol.55 (5), p.239

1998

Volltextzugriff (PDF)

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

The New England journal of medicine, 2014-09, Vol.371 (13), p.1189-1197

2014

Volltextzugriff (PDF)

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

The New England journal of medicine, 2023-03, Vol.388 (12), p.1080-1091

2023

Volltextzugriff (PDF)

Surfactant-facilitated crystallisation of water-soluble foldamers

Chemical science (Cambridge), 2016-01, Vol.7 (5), p.3377-3383

2016

Volltextzugriff (PDF)

Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines

Journal of thrombosis and haemostasis, 2011-09, Vol.9 (9), p.1776-1783

2011

Volltextzugriff (PDF)

Energetic Assessment of Biogas Plant Projects Based on Biowaste and Maize Silage Usage

IOP conference series. Earth and environmental science, 2020-07, Vol.505 (1), p.12029

2020

Volltextzugriff (PDF)

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

The journal of allergy and clinical immunology. Global, 2024-02, Vol.3 (1), p.100195-100195, Article 100195

2024

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(38)
Tagungsberichte
(12)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Humans
(15)
Female
(13)
Life Sciences & Biomedicine
(13)
Male
(12)
Technology
(11)
Adult
(10)
Middle Aged
(10)
Engineering
(9)
Engineering, Electrical & Electronic
(9)
Physics
(7)
Asthma
(6)
Physical Sciences
(6)
Physics, Applied
(5)
Quantum Dot Lasers
(5)
Quantum Dots
(5)
Treatment Outcome
(5)
Absorption
(4)
Allergy
(4)
Biological And Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis

Asthma is associated with enhanced thrombin formation and impaired fibrinolysis

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1

Increased expression of collagen receptors: α1β1 and α2β1 integrins on blood eosinophils in bronchial asthma

Dyspnea is Related to Family Functioning in Adult Asthmatics

Effets sur la sévérité de la dermatite atopique reflétée par les scores EASI et SCORAD chez les patients traités par némolizumab

005 Humanized anti-interleukin-31 receptor A antibody nemolizumab (CIM331) suppresses pruritus and improves eczema in patients with moderate-to-severe atopic dermatitis

C33 NOVEL BIOMARKERS IN LUNG DISEASE: Impaired Fibrinolysis And Lower Levels Of Plasma α2-Macroglobulin Are Associated With An Increased Risk Of Severe Asthma Exacerbations

Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

Étude de phase 2b sur némolizumab chez des patients adultes présentant une dermatite atopique modérée à sévère associée à un prurit sévère

D31 NOVEL MECHANISMS OF ALLERGY AND AIRWAY INFLAMMATION: Enhanced Thrombin Formation And Impaired Fibrinolysis In Persistent Asthma

Autoimmune vasculitis and aortic stenosis in aspirin‐induced asthma (AIA)

Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function

Increased expression of collagen receptors: α 1 β 1 and α 2 β 1 integrins on blood eosinophils in bronchial asthma

Increased expression of collagen receptors: alpha sub(1) beta sub(1) and alpha sub(2) beta sub(1) integrins on blood eosinophils in bronchial asthma

Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma

Changeability of respiratory tract and skin symptoms in patients with asthma-prurigo syndrome under the influence of emotional and environmental factors

Some clinical symptoms and allergens on asthma-prurigo syndrome

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

Surfactant-facilitated crystallisation of water-soluble foldamers

Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines

Energetic Assessment of Biogas Plant Projects Based on Biowaste and Maize Silage Usage

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

Suchergebnisse filtern